Bandingkan Harga & Kinerja Abadi Lestari Indonesia Tbk. (RLCO) vs Organon Pharma Indonesia Tbk. (SCPI)

Abadi Lestari Indonesia Tbk.Trading

Organon Pharma Indonesia Tbk.Trading

Kinerja harga (24 Jam Terakhir)

Statistik utama

Perbedaan Abadi Lestari Indonesia Tbk. dan Organon Pharma Indonesia Tbk.: Abadi Lestari Indonesia Tbk. diperdagangkan di Rp4.500 (kapitalisasi pasar 14,25 T, volume 24 jam 449,7 rb), sedangkan Organon Pharma Indonesia Tbk. diperdagangkan di Rp29.000 (kapitalisasi pasar 104,4 M). Perbedaan utamanya: Abadi Lestari Indonesia Tbk. jauh lebih besar — sekitar 136,5× kapitalisasi pasar Organon Pharma Indonesia Tbk.. Mana yang lebih baik tergantung tujuan investasimu.

	RLCO	SCPI
Kapitalisasi Pasar	14,25 T	104,4 M
Volume	449,7 rb	—
Lot	4,5 rb	—
Perputaran	2 M	—
Harga Rata-rata	4.442,22	—
Nilai Transaksi	2 M	—
Harga Ekuilibrium Indikatif	4.500	—
Volume Ekuilibrium Indikatif	23	—

Lihat detail →Lihat detail →

Perbandingan imbal hasil

Imbal hasil berjalan pada periode standar

Berita terkini

Berita terbaru kedua aset

RLCO

Lihat detail →

SCPI

Lihat detail →

Tentang Abadi Lestari Indonesia Tbk.

PT Abadi Lestari Indonesia (the Entity) was established based on Notarial Deed No. 166 of Siti Nurul Hidajah, S.H., M.Kn., Notary in Bojonegoro, dated August 11, 2014. The Entity started its commercial operations in 2014. PT Abadi Lestari Indonesia is the parent entity, whereas Edwin Pranata is the ultimate beneficial owner of the group.

Selengkapnya di halaman RLCO →

Tentang Organon Pharma Indonesia Tbk.

PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.

Selengkapnya di halaman SCPI →